Omega-6

fatty-acidpolyunsaturated

At a glance

Best for
People with skin conditions (atopic dermatitis) or rheumatoid arthritis seeking GLA-rich oil adjuncts; general population rarely needs supplementation
Typical dose
Linoleic acid: 12–17 g/day from food; GLA supplements: 240–540 mg GLA/day
Time to effect
Weeks to months
Main caution
Most people already overconsume omega-6; supplementation should target specific GLA applications, not general omega-6 intake
Evidence strength: A-grade for essential fatty acid status; B-grade for cardiovascular via diet exchange; C-grade for GLA in atopic dermatitis and RA

What is it

Omega-6 fatty acids are polyunsaturated fatty acids characterized by a double bond at the sixth carbon from the methyl (omega) end of the chain. The parent molecule, linoleic acid (LA, 18:2 n-6) , is an essential nutrient that humans cannot synthesize; it is converted by delta-6 desaturase and elongase to gamma-linolenic acid (GLA, 18:3 n-6) , dihomo-gamma-linolenic acid (DGLA, 20:3 n-6) , and arachidonic acid (AA, 20:4 n-6) . These fatty acids are structural components of cell membranes and substrates for eicosanoid signaling: arachidonic acid is the precursor of pro-inflammatory prostaglandins (PGE2), leukotrienes (LTB4), and thromboxanes, while DGLA gives rise to anti-inflammatory PGE1. Supplemental omega-6 sources include borage oil, evening primrose oil, black currant seed oil (GLA-rich), and most seed oils (LA-rich).

Is it worth it for you?

Worth considering if…

  • You have atopic dermatitis and want to try GLA-rich evening primrose or borage oil
  • You have rheumatoid arthritis and are trying GLA as an adjunct
  • You have confirmed essential fatty acid deficiency

Probably skip if…

  • You eat a typical Western diet (you almost certainly already exceed adequate intake)
  • You are on anticoagulants or have a bleeding disorder without medical guidance
  • You are on phenothiazine antipsychotics or have a seizure disorder (borage and EPO may lower seizure threshold)

Evidence at a glance

GoalEvidenceEffectBest fitTime
essential fatty acid adequacyStrongCorrects EFA deficiency when LA intake meets adequate intakePeople with fat malabsorption, very-low-fat diets, or prolonged fat-free parenteral nutritionWeeks
cardiovascular risk reduction via saturated fat replacementGood~10–15% LDL reduction when LA-rich oils replace saturated fat in dietAdults replacing saturated fat sources with polyunsaturated vegetable oilsWeeks to months for lipid changes
atopic dermatitis with GLA-rich oilsMixedModest reduction in itch and skin severity scores in some trials; inconsistentAdults and children with mild-to-moderate atopic dermatitis8–16 weeks

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

essential fatty acid adequacy

Corrects deficiency
Strong

Linoleic acid (the parent omega-6) is a dietary essential fatty acid required for membrane phospholipids, skin barrier integrity, and arachidonic acid production. True EFA deficiency is rare in any diet containing vegetable oils and manifests as scaly dermatitis, growth failure, and reproductive problems. The AI of 1217 g/day is easily met through normal food.

Effect size: Corrects EFA deficiency when LA intake meets adequate intake
Time to effect: Weeks
Best fit: People with fat malabsorption, very-low-fat diets, or prolonged fat-free parenteral nutrition
Less likely: Anyone on a normal diet containing vegetable oils

Bottom line: Meeting adequate omega-6 intake prevents EFA deficiency; supplementation is not needed in typical diets.

cardiovascular risk reduction via saturated fat replacement

Supplement benefit
Good

Meta-analyses show that replacing saturated fat with linoleic acid-rich polyunsaturated oils reduces LDL cholesterol and lowers coronary heart disease risk. This is a dietary exchange effect, not a standalone supplement effect. Adding more omega-6 without reducing saturated fat provides much less benefit.

Effect size: ~10–15% LDL reduction when LA-rich oils replace saturated fat in diet
Time to effect: Weeks to months for lipid changes
Best fit: Adults replacing saturated fat sources with polyunsaturated vegetable oils
Less likely: People adding omega-6 on top of an already high-fat diet

Bottom line: Replacing saturated fat with LA-rich vegetable oils is a dietary strategy with B-level evidence; isolated omega-6 supplementation is not.

atopic dermatitis with GLA-rich oils

Supplement benefit
Mixed

GLA (gamma-linolenic acid) from evening primrose oil or borage oil is proposed to correct an impaired delta-6-desaturase step in atopic dermatitis. Some RCTs show modest improvement in itch, erythema, and scaling scores; larger, better-controlled trials are often neutral. Cochrane reviews give a tentative finding of possible modest benefit that is not robust across all trials.

Effect size: Modest reduction in itch and skin severity scores in some trials; inconsistent
Time to effect: 8–16 weeks
Best fit: Adults and children with mild-to-moderate atopic dermatitis
Less likely: Severe atopic dermatitis requiring prescription therapy

Bottom line: GLA-rich oils may modestly improve atopic dermatitis symptoms; evidence is inconsistent and effect sizes are small.

Evidence is mixed

Early trials were positive; later and larger RCTs and Cochrane analyses found effects that were modest and heterogeneous, limiting confidence.

How to take it

Typical dose
For GLA: evening primrose oil 3–6 g/day (~270–540 mg GLA) or borage oil 1–3 g/day (~200–600 mg GLA)
Timing
With meals for best absorption
With food
With food; fat-containing meals improve absorption
How long to try
Trial 8–24 weeks for atopic dermatitis or RA before judging response

What to track

  • Skin symptoms or eczema severity
  • Joint pain and swelling if used for RA
  • Any unusual bruising or bleeding
  • GI tolerance

Safety

Common side effects

GI upset, soft stools, belching with borage or evening primrose oil, Mild bloating

Serious risks

  • Borage oil may contain pyrrolizidine alkaloids (hepatotoxic) if not certified PA-free
  • Evening primrose and borage oil may lower seizure threshold in susceptible individuals

Who should avoid it

  • People with epilepsy or on phenothiazines
  • People on warfarin or DOACs without medical guidance
  • Pre-surgical patients (discontinue 1–2 weeks before surgery)

Pregnancy & breastfeeding

Dietary omega-6 from food is safe in pregnancy; high-dose GLA supplements (borage, EPO) have insufficient safety data and should be avoided unless specifically recommended by a provider.

Interactions

warfarin / DOACsModerate

High-dose GLA oils modestly prolong bleeding time; monitor INR and inform prescriber

phenothiazine antipsychoticsModerate

Evening primrose and borage oils may lower seizure threshold in combination

antiplatelet agents (aspirin, clopidogrel)Minor

Additive antiplatelet effect; flag before surgery

Choosing a product

Look for

  • GLA content stated in mg per dose (not just oil weight)
  • PA-free certification for borage oil
  • Third-party tested for heavy metals and purity

Be skeptical of

  • Anti-inflammatory omega-6
  • Balances your omega-3:6 ratio (supplementation raises omega-6 further)
  • Treats eczema or arthritis definitively

References by claim

essential fatty acid adequacy

  • Wolff et al., 2025PMC (2025) link
  • Shrestha et al., 2022PMC (2022) link

cardiovascular risk reduction via saturated fat replacement

  • Mozaffarian et al., 2010PMC (2010) link

atopic dermatitis with GLA-rich oils

  • Niseteo et al., 2024PMC (2024) link

Track Omega-6 with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.